Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Prostate Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Weill Cornell Medicine, New York, New York, United States
Contact: Study coordinator (Fabiana Gregucci, M.D.) · fgr4002@med.cornell.edu · 646-962-3110
Contact: Study coordinator (Dakota Trick) · dat4015@med.cornell.edu · 646-962-3118
Contact: Principal Investigator (Silvia Formenti, M.D.)

Study leads

Silvia Formenti, M.D.
Principal Investigator
Weill Medical College of Cornell University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Stem Cells for Erectile Dysfunction Post RALP

Erectile Dysfunction · Prostate Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Houston, United States

XL092 in Patients With Metastatic Castration-Resistant Prostate Cancer

Metastatic Castration-resistant Prostate Cancer

Abroad (travel likely)RecruitingPHASE2

Salt Lake City, United States

Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy

Prostate Adenocarcinoma · Prostate Cancer · Localized Prostate Cancer

Abroad (travel likely)RecruitingPHASE2

San Francisco, United States · St Louis, United States

ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer

Metastatic Castration-Resistant Prostate Cancer

Abroad (travel likely)RecruitingPHASE2

Los Angeles, United States · San Francisco, United States